Determining Highest Dose Administration of TC-5214 and Evaluating Effect on the Electrical Activity in the Heart

NCT01359618 · clinicaltrials.gov ↗

PHASE1

Phase

TERMINATED

Status

16

Enrollment

INDUSTRY

Sponsor class

Stopped Sponsor decision to terminate

Conditions

Healthy Male

Interventions

DRUG: TC-5214
OTHER: Placebo comparator
DRUG: Moxifloxacin
OTHER: Moxifloxacin placebo comparator

Sponsor

AstraZeneca